Rectal cancer: Integrating oxaliplatin into chemoradiation studies

ONCOLOGY

Volumn 14, Issue 12 SUPPL. 11, 2000, Pages 38-41

  Ryan, David P ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; OXALIPLATIN; PLATINUM COMPLEX;

CANCER STAGING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA; MAXIMUM TOLERATED DOSE; MULTIMODALITY CANCER THERAPY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; RECTUM TUMOR; REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE II; CLINICAL TRIALS, PHASE III; COMBINED MODALITY THERAPY; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; LEUKEMIA; MAXIMUM TOLERATED DOSE; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIALS; RECTAL NEOPLASMS;

EID: 0034572295     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. American Cancer Society website: Cancer Facts and Figures 2000. Available at: http://www.cancer.org/statistics/cff2000/selectedcancers.html. Accessed August 29, 2000.
2. Gastrointestinal Tumor Study Group: Adjuvant therapy of colon cancer: Results of a prospectively randomized trial. N Engl J Med 310:737-743, 1984.
3. O'Connell MJ, Martenson JA, Weiand HS, et al: Improving adjuvant therapy for rectal cancer by combining protracted infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331;502-507, 1994.
4. Douglass HO Jr, Moertel CG, Mayer RJ, et al: Survival after postoperative combination treatment of rectal cancer. N Engl J Med 315:1294-1295, 1986.
5. Fisher B, Wolmark N, Rockette H, et al: Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: Results from NS-ABP protocol R-01. J Natl Cancer Inst 80:21-29, 1988.
6. Krook JE, Moertel CG, Gunderson LL, el al: Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324:709-715, 1991.
7. Tepper JE, O'Connell MJ, Petroni GR, et al: Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: Initial results of Intergroup 0114. J Clin Oncol 15:2,030-2,039, 1997.
8. Wolmark N, Wieand S, Hyams D, et al: Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 92:388-396, 2000.
9. Merchant NB, Guillem JG, Paty PB, et al: T3N0 rectal cancer: Results following sharp mesorectal excision and no adjuvant therapy. J Gastrointest Surg 3:642-647, 1999.
10. Willett CG, Badizadegan K, Ancukiewicz M, et al: Prognostic factors in stage T3N0 rectal cancer: Do all patients require postoperative pelvic irradiation and chemotherapy? Dis Colon Rectum 42:167-173, 1999.
11. Rich TA, Skibber JM, Ajani JA, et al. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Inl J Radiat Oncol Biol Phys 32:1025-1029, 1995.
12. Chari RS, Tyler DS, Anscher MS, et al: Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg 221:778-786, 1995.